272 related articles for article (PubMed ID: 22475084)
21. Excess breast cancer risk and the role of parity, age at first childbirth and exposure to radiation in infancy.
Holmberg E; Holm LE; Lundell M; Mattsson A; Wallgren A; Karlsson P
Br J Cancer; 2001 Aug; 85(3):362-6. PubMed ID: 11487266
[TBL] [Abstract][Full Text] [Related]
22. Increased risk of second cancer among patients with ovarian borderline tumors.
Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G
Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966
[TBL] [Abstract][Full Text] [Related]
23. Risks of breast, endometrial, and ovarian cancers after twin births.
Ji J; Försti A; Sundquist J; Hemminki K
Endocr Relat Cancer; 2007 Sep; 14(3):703-11. PubMed ID: 17914100
[TBL] [Abstract][Full Text] [Related]
24. Fertility drugs and cancer: a guideline.
;
Fertil Steril; 2016 Dec; 106(7):1617-1626. PubMed ID: 27573989
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of ovarian and uterine cancers in a cohort of in vitro fertilization patients.
Venn A; Jones P; Quinn M; Healy D
Gynecol Oncol; 2001 Jul; 82(1):64-8. PubMed ID: 11426963
[TBL] [Abstract][Full Text] [Related]
26. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization.
Dor J; Lerner-Geva L; Rabinovici J; Chetrit A; Levran D; Lunenfeld B; Mashiach S; Modan B
Fertil Steril; 2002 Feb; 77(2):324-7. PubMed ID: 11821091
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study.
Orgéas CC; Sanner K; Hall P; Conner P; Holte J; Nilsson SJ; Sundfeldt K; Persson I; Chia KS; Wedren S; Dickman PW; Czene K
Am J Obstet Gynecol; 2009 Jan; 200(1):72.e1-7. PubMed ID: 19121659
[TBL] [Abstract][Full Text] [Related]
28. Cancer risk associated with subfertility and ovulation induction: a review.
Klip H; Burger CW; Kenemans P; van Leeuwen FE
Cancer Causes Control; 2000 Apr; 11(4):319-44. PubMed ID: 10843444
[TBL] [Abstract][Full Text] [Related]
29. Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study.
Gottschau M; Kjaer SK; Jensen A; Munk C; Mellemkjaer L
Gynecol Oncol; 2015 Jan; 136(1):99-103. PubMed ID: 25451694
[TBL] [Abstract][Full Text] [Related]
30. Association between fertility drugs and gynecologic cancers, breast cancer, and childhood cancers.
Ayhan A; Salman MC; Celik H; Dursun P; Ozyuncu O; Gultekin M
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1104-11. PubMed ID: 15548140
[TBL] [Abstract][Full Text] [Related]
31. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation.
Williams CL; Jones ME; Swerdlow AJ; Botting BJ; Davies MC; Jacobs I; Bunch KJ; Murphy MFG; Sutcliffe AG
BMJ; 2018 Jul; 362():k2644. PubMed ID: 29997145
[TBL] [Abstract][Full Text] [Related]
32. Cancer incidence in a cohort of infertile women.
Ron E; Lunenfeld B; Menczer J; Blumstein T; Katz L; Oelsner G; Serr D
Am J Epidemiol; 1987 May; 125(5):780-90. PubMed ID: 3565353
[TBL] [Abstract][Full Text] [Related]
33. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
[TBL] [Abstract][Full Text] [Related]
34. Fertility drug use and risk of ovarian tumors: a debated clinical challenge.
Gadducci A; Guerrieri ME; Genazzani AR
Gynecol Endocrinol; 2013 Jan; 29(1):30-5. PubMed ID: 22946709
[TBL] [Abstract][Full Text] [Related]
35. BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.
Einbeigi Z; Enerbäck C; Wallgren A; Nordling M; Karlsson P
Acta Oncol; 2010 Apr; 49(3):361-7. PubMed ID: 20151938
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer risk associated with ovulation-stimulating drugs.
Brinton LA; Scoccia B; Moghissi KS; Westhoff CL; Althuis MD; Mabie JE; Lamb EJ
Hum Reprod; 2004 Sep; 19(9):2005-13. PubMed ID: 15217997
[TBL] [Abstract][Full Text] [Related]
37. Long-term cancer risk among Swedish women with cosmetic breast implants: an update of a nationwide study.
McLaughlin JK; Lipworth L; Fryzek JP; Ye W; Tarone RE; Nyren O
J Natl Cancer Inst; 2006 Apr; 98(8):557-60. PubMed ID: 16622125
[TBL] [Abstract][Full Text] [Related]
38. Cancer incidence in Israeli Jewish survivors of World War II.
Keinan-Boker L; Vin-Raviv N; Liphshitz I; Linn S; Barchana M
J Natl Cancer Inst; 2009 Nov; 101(21):1489-500. PubMed ID: 19861305
[TBL] [Abstract][Full Text] [Related]
39. Ovulation induction treatment and risk of borderline ovarian tumors.
Cusidó M; Fábregas R; Pere BS; Escayola C; Barri PN
Gynecol Endocrinol; 2007 Jul; 23(7):373-6. PubMed ID: 17701767
[TBL] [Abstract][Full Text] [Related]
40. A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer.
Hogervorst JG; Schouten LJ; Konings EJ; Goldbohm RA; van den Brandt PA
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2304-13. PubMed ID: 18006919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
